Short Interest in Arcadia Biosciences, Inc. (NASDAQ:RKDA) Decreases By 21.3%

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a significant decrease in short interest in November. As of November 15th, there was short interest totalling 19,600 shares, a decrease of 21.3% from the October 31st total of 24,900 shares. Based on an average trading volume of 14,400 shares, the short-interest ratio is currently 1.4 days. Currently, 1.4% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

RKDA has been the subject of several research analyst reports. HC Wainwright reaffirmed a “buy” rating and set a $6.00 target price on shares of Arcadia Biosciences in a research report on Wednesday, August 21st. StockNews.com started coverage on shares of Arcadia Biosciences in a research note on Sunday. They issued a “sell” rating on the stock.

Arcadia Biosciences Price Performance

Shares of RKDA traded up $0.03 during mid-day trading on Friday, hitting $2.79. The stock had a trading volume of 14,014 shares, compared to its average volume of 11,308. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $5.34. The business has a fifty day moving average price of $3.32 and a 200-day moving average price of $3.07. The firm has a market cap of $3.79 million, a P/E ratio of -0.65 and a beta of 1.27.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.